MedTrace Logo

Cell Therapy in Chronic Ischemic Heart Disease

NCT00362388 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2010-01-27

No results posted yet for this study

Summary

This study was designed to test the hypothesis that direct injection of bone-marrow cells in the heart may increase the number of blood vessels, ameliorating the heart's performance, and relieving patients from symptoms like angina and/or shortness of breath.

Conditions

Interventions

PROCEDURE

Intramyocardial injection of autologous bone marrow cells

Sponsors & Collaborators

  • Ministry of Science and Technology

    collaborator AMBIG

  • Ministry of Health, Brazil

    lead OTHER_GOV

Principal Investigators

  • Sergio A. de Oliveira, MD, PhD · Heart Institute (InCor), Hospital das Clinicas, University of São Paulo Medical School

  • Jose Eduardo Krieger, MD, PhD · Heart Institute (InCor), Hospital das Clinicas, University of São Paulo Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00362388 on ClinicalTrials.gov